Edition:
United Kingdom

Albireo Pharma Inc (ALBO.OQ)

ALBO.OQ on NASDAQ Stock Exchange Capital Market

28.40USD
22 Mar 2019
Change (% chg)

-- (--)
Prev Close
$28.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
12,500
52-wk High
$37.67
52-wk Low
$19.43

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -1.30 December 25 Mar 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 4 3 3 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.43 1.43 1.43

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 8 0.90 3.00 0.00 --
Quarter Ending Jun-19 8 1.22 5.00 0.00 --
Year Ending Dec-19 8 5.05 20.00 0.00 7.64
Year Ending Dec-20 8 14.60 42.57 0.00 26.55
Earnings (per share)
Quarter Ending Mar-19 8 -1.30 -1.10 -1.46 --
Quarter Ending Jun-19 8 -1.38 -0.99 -1.63 --
Year Ending Dec-19 8 -5.65 -4.07 -7.05 -3.49
Year Ending Dec-20 8 -5.35 -4.20 -7.10 -3.87

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-18 1.14 0.57 0.57 50.11
Quarter Ending Sep-18 0.89 0.24 0.65 73.42
Quarter Ending Jun-18 0.57 0.73 0.16 27.76
Quarter Ending Mar-18 31.32 11.20 20.11 64.23
Quarter Ending Dec-17 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 0.90 1.37 1.59 1.59 --
Quarter Ending Jun-19 1.22 1.82 2.13 2.13 --
Year Ending Dec-19 5.05 6.95 7.77 7.77 7.64
Year Ending Dec-20 14.60 18.31 21.15 21.15 26.55

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 1 0 1
Quarter Ending Jun-19 0 2 0 2
Year Ending Dec-19 0 3 0 3
Year Ending Dec-20 0 3 0 3
Earnings